NRJ GROUP (EPA:NRG) | Finanzwire

Basculer en Français

8296	Companies
114902	Keywords
55328	Articles
62458	Press releases

Home
Companies
NRJ GROUP

REGULATED PRESS RELEASE

published on 03/29/2024 at 18:12, 7 months 22 days ago

NRJ Group - Availability of the 2023 Universal Registration Document
NRJ GROUP releases its 2023 Universal Registration Document including financial and governance reports, now available for public consultation on the company and AMF websites

NRJ GROUP AMF Financial Reports Universal Registration Document Governance Reports
BRIEF

published on 03/28/2024 at 17:45, 7 months 23 days ago

NRJ Group confirms its eligibility for the PEA-PME system

NRJ GROUP Taxation Finance PEA-SME Eligibility
ARTICLE

published on 03/20/2024 at 18:18, 8 months ago

NRJ GROUP announces its 2023 annual results showing strong growth
The group shows significant growth in its financial results in 2023

Financial Results NRJ GROUP Dividend Growth Media
BRIEF

published on 03/20/2024 at 17:58, 8 months ago

NRJ GROUP Announces Strong Annual Results for 2023

NRJ GROUP Financial Performance Dividends Annual Results 2023 Media Growth
REGULATED PRESS RELEASE

published on 03/20/2024 at 17:53, 8 months ago

NRJ GROUP - Press release annual results 2023
NRJ Group reports strong growth in consolidated results for the 2023 financial year with an increase in operating profit and proposed dividend. The Board of Directors approved the annual accounts on 20 March 2024

Board Of Directors NRJ GROUP Operating Profit Financial Year Dividend
BRIEF

published on 03/04/2024 at 14:21, 8 months 16 days ago

NRJ Group announces its voting rights as of February 28, 2024

NRJ GROUP Share Capital Voting Rights AMF Financial Markets
REGULATED PRESS RELEASE

published on 02/01/2024 at 17:45, 9 months 19 days ago

NRJ GROUP - Press release - 2023 revenue
NRJ Group reports continued strong growth in consolidated revenue for the 4th quarter of 2023, with radio and broadcasting activities leading the way, despite a slight drop in television revenue. The impressive audience share and commercial performance of NRJ's radio stations also contributed to this solid performance

NRJ GROUP Consolidated Revenue Radio Activity Television Revenue Audience Share
REGULATED PRESS RELEASE

published on 11/08/2023 at 17:52, 1 year ago

NRJ GROUP - Financial Information Q3 2023

Accesswire

Published on 11/21/2024 at 13:00, 37 minutes ago

Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 37 minutes ago

Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 37 minutes ago

Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Published on 11/21/2024 at 13:00, 37 minutes ago

Nextech3D.ai Spin-Out Rebrands as FOTOgpt.ai to Usher in a New Era of AI-Powered Photography
Published on 11/21/2024 at 13:00, 37 minutes ago

Clean Air Metals Announces Positive Results from Innovative Seismic Survey at the Escape Deposit Down-Plunge Extension

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 13:15, 22 minutes ago

NOTICE OF ANNUAL GENERAL MEETING
Published on 11/21/2024 at 12:35, 1 hour 2 minutes ago

audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 22 minutes ago

Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 12:06, 1 hour 30 minutes ago

IVU AG publishes Quarterly Report Q3-2024
Published on 11/21/2024 at 12:00, 1 hour 37 minutes ago

Holding(s) in Company

Les Echos

Published on 11/21/2024 at 06:58, 6 hours 39 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 17 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 19 hours 52 minutes ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 19 hours 52 minutes ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 5 hours ago

Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo

View all LES ECHOS COMFI WIRE